| Document Date: 2010-04-04 01:15:12
Open Document File Size: 235,91 KBShare Result on Facebook
Company Merck & Co. Inc. / Merck / Less Common Adverse Reactions / / Currency pence / / Event FDA Phase / / Facility Laboratory Abnormalities The / Laboratory Parameter Preferred Term LDL / Laboratory Abnormalities Reported / Laboratory Parameter Preferred Term / / IndustryTerm treatment / Monitor for Immune Reconstitution Syndrome / treatment of HIV / chemical name / medicinal products / food / / MedicalCondition inflammatory response / cancers / abdominal pain / insomnia / Pneumocystis jiroveci pneumonia / cancer / HIV / Nervous System Disorders / headache / Myopathy / genital herpes / Mycobacterium tuberculosis / antierectile dysfunction / Carcinogenesis / chronic / nausea / Hepatitis C / Hepatitis B / rhabdomyolysis / Stevens-Johnson syndrome / Fatigue / concomitant disease / varicella zoster virus / Psychiatric Disorders Insomnia / residual opportunistic infections / AIDS / infection / illness / depression / Infections / rash / Immune Reconstitution Syndrome / / MedicalTreatment antiretroviral treatment / antiretroviral therapy / drug therapy / / Organization Dosage And Administration / FDA / / / Position investigator / General / / Product efavirenz / phenytoin / talc / polyethylene glycol / lamivudine / ISENTRESS / omeprazole / rifampin / OBT ISENTRESS / ISENTRESS Efavirenz / ISENTRESS Placebo / placebo / / PublishedMedium Baseline / / Technology Pharmacokinetics / Pharmacodynamics / UDP / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS (raltegravir) Tablets In